The Translational Glycomics Symposium

Project Summary The 2024 Translational Glycomics Symposium, organized by the Translational Glycomics Center at Versiti Blood Research Institute in Milwaukee, Wisconsin, is set for September 26-27, 2024. This annual event is dedicated to advancing translational glycobiology and nurturing emerging researchers. The symposium's primary goals are

to give trainees and early-stage investigators opportunities to develop collaborative research and increase the visibility of glycoscience in basic, translational, and clinical disciplines. As a complimentary event, it welcomes diverse experts to present their findings to the broader glycoscience and clinical-translational community,

including those at the beginning of their careers. The symposium covers glycobiology related topics in aging, inflammation, immunology, classical and malignant hematology, solid cancer, and regenerative medicine, offered in a hybrid format for both in-person and online participants. It serves as an essential resource for

researchers and clinicians in glycoscience, offering opportunities for networking, collaboration, and learning about the latest developments in the field. With a strong commitment to supporting trainees and early-stage investigators, particularly from underrepresented backgrounds, the symposium ensures accessibility and

inclusivity for all attendees. The specific aims of the program are: 1. Empower Trainees and Early-Stage Investigators: Provide a dynamic platform for trainees and early- stage investigators, particularly those from underrepresented groups, to present their research, receive constructive feedback, and forge future collaborations, thereby nurturing the next generation of

glycoscience researchers. 2. Foster Collaborative Research in Translational Glycoscience: Create opportunities for collaboration among glycoscience researchers, interdisciplinary researchers, and physician-scientists to enhance research outcomes and innovations in the field. 3. Enhance Glycoscience Visibility: Highlight the significance and clinical implications of glycoscience,

encouraging its integration into broader scientific discussions and analyses. 4. Promote Specialized Training: Address the deficiency of glycoscience expertise in biomedical institutions by offering specialized training and educational resources. Facilitate the integration of clinical trainees into glycosciences and basic science trainees into translational medicine, ensuring the efficient

translation of novel glyco-concepts from laboratory research to enhanced patient care. Through these aims, the Translational Glycomics Symposium aspires to be a catalyst for groundbreaking research and transformative developments in glycoscience, ultimately contributing to improving patient care and

treatment methodologies.